-> -> ð -> ð    
 
Apogee`{ʽаl
Դ: Admin    •rg: 2020-03-05    g[: 116 ˴

͹ڠCOVID-2019Ŀǰ΄ȻڮǰlFxǮǰcֹĿǰᘌ˲ίmȻڲаlMȻПoЧη͹ڠаlɹlԁ͹ڠNѸٳɹxаlĿļr헹PаlȡAԵijɹȻаlһs^ҪׂµĕrgS҇ЌҵRąf˕rDŲõČCOVID-2019һаlɹ՞COVID-2019AίṩЧη


ӢApogee Flow˾{ʽxʼKע{wͬӿɞ鲡wȼ{wаlPṩЧIĽQ


@Ĭ˼FHCMVаlҷβApogee`{ʽٸͨƷԼڼٲаlг`{ʽṩĽQ


˾޼( human cytomegalovirus HCMV) ǰ dsDNA HCMVȺеĸȾdzձԸȾҊIJ֮һ, ЋD̥Σ^, ḁ̥lt ϵKϵytĿǰᘌHCMVПoЧίֶаlخAһֱԁᘌHCMVăȼо


ڲаl^wǷdzPIĭhyķهڲ׻Ⱦ@NкܴľͬһN͵IJвͬ͵IJwHCMVwȾԲwǸȾСwͰĤwвͬwyͬ|ĤcOͨ^|خԿԭMвwą^mȻ30ǰоˆTLԇʽwоGaudinͬʽʾ˲ǵםȺͲȾԵPϵڂyʽɢzy`ȵľµķOͷȻؽ


Ĭ˼FаlˆTJosef Vlasakͨ^ڜpAD169ϻ֏ͱ_gHȫµHCMV{ʽrOزwralKӷN߷ȡشͻԓ߃ݞȫسʬFHCMVǵҿӏҵCD8+߼M?ͬ͵ϸ}ܸ?ǰѽ̎R{ʽаlˆT]ʹ˘O߼gɫӢApogee˾`{ʽxԓxHHͨ^ɢApogee {ʽ ռƷԵıϢD 1ζȺwȵϢ



D 1.{ʽ^ֲͬСHCMVwϢ

purif. NIEPsǸȾ԰Ĥw

purif. virionsȾԵIJw

purif. Large DBСw

unfractionated: NwĻͬIJwСߴ粻ͬ



@ЩϢp׵ث@ȡʽЩ͕rgęzyʽ׌rرOyNwķˮƽD 2OؼӿƄаlɞ



D 2. {ʽrOy

ͬ̎l²wķˮƽ

       ̎lԽwˮƽԽ


YߟɹApogee {ʽ߀ԷHCMVPIԭgBgHڲͬwϵķֲD 3OزwļJosef Vlasak˽HCMV{ʽoHCMVϢаl޴ıͬrҲоNĴ󲡶wзdzҪąrֵ



D 3. gBɹӛ^ֲͬ̎lµIJwvirionsNIEPsͷDzw

̎lԽDzwԽ


ҪfApogee Micro PlusڸͨаlPпҪwF¼gɫ


>>ɌFöǶɢzy100nmҵIJwɢֱ_10nmͬСͬΑBY

>>49ɫɹ3Nɢ⌦Mж

>>Ӌʽ龫ʽ^Ӌo˜΢ֱϘӌwMоӋ

>>oIJoُIʽoُIҺ

>>ݸͨԄϘӷ֧96װƷԄϘӷʡ

>>ʳCֲ֧Сʷ


Apogee{ʽxɞδIJٲ_lṩQش鲡lFAؕIg֧



īI

Flask J, Hoang V M, Christanti S, et al. Use of flow cytometry for characterization of human cytomegalovirus vaccine particles[J]. Vaccine.


gӭPעRٷ΢ţ΢Ź̖Bio-Gene
؏ͣapogee鿴Pҕl
L¶SaRePע̖

RƼ޹˾
Bio-Gene Technology Ltd.
VݲRƼ޹˾
ᾀ176 2009 3784
㽭15ѡ5 www.oliqz.com

Ϻ V ɶ h

 
 
 
 

ľW      @

  ©1993-2020 ۲RƼ޹˾  |  I]  |  
ۿ˾ַɳﰲƽְ̖_Ķʮʮ    Ԓ+852-26466101    棺+852-2686 8806    E-mail㽭15ѡ5
Ї“jcVݲRƼ޹˾    “ϵԒ176 2009 3784    E-mail[email protected]